Clinical Evaluation is the ongoing methodological process of assessing a medical device's safety and performance through the analysis of clinical data. It is not a single study but a lifecycle-wide program that verifies the device achieves its intended use without exposing patients or users to disproportionate risk, forming the core of regulatory submissions like the 510(k) or PMA.
Glossary
Clinical Evaluation
The systematic and planned process to continuously generate, collect, analyze, and assess the clinical data pertaining to a medical device to verify its safety and performance, including Software as a Medical Device (SaMD).
REGULATORY FOUNDATION
What is Clinical Evaluation?
A systematic, planned process for continuously generating, collecting, analyzing, and assessing clinical data to verify the safety and performance of a medical device throughout its lifecycle.
The process is mandated by standards such as ISO 14155 and regional regulations like the EU MDR. It requires a documented Clinical Evaluation Plan (CEP) and culminates in a Clinical Evaluation Report (CER). For Software as a Medical Device (SaMD), this evaluation must rigorously demonstrate analytical validation, clinical association, and clinical validation using a hierarchy of evidence.
SYSTEMATIC EVIDENCE GENERATION
Core Components of a Clinical Evaluation
A clinical evaluation is a methodologically sound, ongoing process to generate, collect, analyze, and assess clinical data for a medical device. The goal is to verify its safety and clinical performance throughout its lifecycle.
01
Clinical Evaluation Plan (CEP)
The foundational document that defines the scope, methodology, and acceptance criteria for the entire evaluation. It must be established before any data collection begins.
- Defines the device's intended purpose and target population
- Specifies the clinical safety and performance endpoints to be verified
- Outlines the systematic literature review protocol
- Justifies the sufficiency of data to be generated or gathered
02
Identification of Clinical Data
A systematic process to gather all relevant data, whether generated by the manufacturer or sourced from external literature. This phase distinguishes between pre-market and post-market data sources.
- Generated Data: Results from manufacturer-sponsored clinical investigations
- Gathered Data: Scientific literature, competitor device data, and registry reports
- Requires a documented, reproducible search strategy to prevent selection bias
03
Appraisal of Clinical Data
Each data set must be rigorously evaluated for its scientific validity, relevance, and weighting. This step ensures that only high-quality evidence contributes to the final safety and performance conclusions.
- Assesses study design, statistical power, and potential confounding factors
- Evaluates the applicability of data to the device under evaluation
- Determines the contribution of each data set to the overall clinical picture
04
Analysis of Clinical Data
The synthesis of all appraised data to reach definitive conclusions. This involves a structured comparison of the device's benefits against its residual risks, directly supporting the benefit-risk determination.
- Confirms conformity with relevant General Safety and Performance Requirements (GSPRs)
- Addresses any identified gaps in the clinical evidence
- Forms the basis for the final Clinical Evaluation Report (CER)
05
Clinical Evaluation Report (CER)
The living document that encapsulates the entire evaluation process. It is not a static submission but a dynamic record that must be updated continuously with post-market surveillance data.
- Summarizes the literature review, data appraisal, and analysis
- Provides a clear, evidence-based conclusion on the device's safety and performance
- Serves as the primary regulatory submission artifact for notified bodies and the FDA
06
Post-Market Clinical Follow-up (PMCF)
A proactive, continuous cycle of data collection after market release to confirm long-term safety and performance. PMCF bridges the gap between controlled pre-market studies and real-world clinical use.
- Detects rare complications or long-term device failures
- Updates the benefit-risk profile with real-world evidence
- Mandated by EU MDR for ongoing CE marking maintenance
CLINICAL EVALUATION FAQ
Frequently Asked Questions
Essential questions and answers about the systematic process of generating, collecting, and analyzing clinical data to verify the safety and performance of Software as a Medical Device (SaMD).
A clinical evaluation is a systematic and planned process to continuously generate, collect, analyze, and assess the clinical data pertaining to a medical device to verify its safety and performance, including clinical benefits, throughout its lifecycle. For Software as a Medical Device (SaMD), this process is a mandatory regulatory requirement under frameworks like the EU Medical Device Regulation (MDR) 2017/745 and is integral to FDA premarket submissions. The evaluation is not a single study but an ongoing lifecycle activity designed to demonstrate that the algorithm achieves its Intended Use without posing unacceptable risks to patients. It forms the core of the Clinical Evaluation Report (CER), bridging the gap between technical Analytical Validation and real-world clinical utility by proving the device's output leads to a meaningful, safe clinical outcome.
Enabling Efficiency, Speed & Accuracy
Intelligent Analysis, Decision & Execution
We build AI systems for teams that need search across company data, workflow automation across tools, or AI features inside products and internal software.
Talk to Us
Search across company data
Give teams answers from docs, tickets, runbooks, and product data with sources and permissions.
Useful when people spend too long searching or get different answers from different systems.
Enterprise searchRAGPermissions
Read more
Automate internal workflows
Use AI to route work, draft outputs, trigger actions, and keep approvals and logs in place.
Useful when repetitive work moves across multiple tools and teams.
AI agentsWorkflow automationGovernance
Read more
Add AI to products and internal tools
Build assistants, guided actions, or decision support into the software your team or customers already use.
Useful when AI needs to be part of the product, not a separate tool.
AI integrationDecision supportModel routing
Read more
About the author
Prasad Kumkar
CEO & MD, Inference Systems
Prasad Kumkar is the CEO & MD of Inference Systems and writes about AI systems architecture, LLM infrastructure, model serving, evaluation, and production deployment. Over 5+ years, he has worked across computer vision models, L5 autonomous vehicle systems, and LLM research, with a focus on taking complex AI ideas into real-world engineering systems.
His work and writing cover AI systems, large language models, AI agents, multimodal systems, autonomous systems, inference optimization, RAG, evaluation, and production AI engineering.
LinkedIn
Limited slotsGet a Free AI Consultation
Partnered with leading AI, data, and software stack.
How We Work
Custom AI workflows for your Business
One-fit-all AI don't work for modern businesses. At Inferensys, we aim to understand your business & custom requirements; which we use to define most efficient agentic workflows, the data, and the tools for your business.
01
Review the use case
We understand the task, the users, and where AI can actually help.
Read more02
Pick the right approach
We define what needs search, automation, or product integration.
Read more03
Build the first useful version
We implement the part that proves the value first.
Read more04
Improve from there
We add the checks and visibility needed to keep it useful.
Read moreThe first call is a practical review of your use case and the right next step.
Talk to Us